Invivyd (IVVD) Cash from Operations (2021 - 2025)
Invivyd (IVVD) reported Cash from Operations of 15455000.0 for Q4 2025, up 58.91% on a YoY basis from 9725801.89 in Q4 2024, and down 87.33% quarter-over-quarter from 8250000.0 in Q3 2025.
Invivyd (IVVD) Cash from Operations (2021 - 2025) Analysis & Trends
Invivyd has reported Cash from Operations for 5 years, with the latest figure at 15455000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Operations rose 58.91% year-over-year to 15455000.0; the trailing twelve-month figure through Dec 2025 stood at 58135000.0 (up 65.9% YoY), and the FY2025 full-year result was 58135000.0, up 65.9% from the prior year.
- Cash from Operations for Q4 2025 stood at 15455000.0, down from 8250000.0 in the prior quarter.
- The five-year high for Cash from Operations was 8250000.0 in Q3 2025, with the low at 73212000.0 in Q4 2021.
- Historically, Cash from Operations has averaged 40325650.0 across 5 years, with a median of 41124500.0 in 2023.
- Annual changes were most pronounced in 2022 — Cash from Operations plunged 148.72% — and 2025, when it surged 79.91%.
- Invivyd's Cash from Operations stood at 73212000.0 in 2021, then soared by 35.25% to 47404000.0 in 2022, then retreated by 24.97% to 59240000.0 in 2023, then jumped by 36.51% to 37610000.0 in 2024, then jumped by 58.91% to 15455000.0 in 2025.
- The last three Cash from Operations figures came in at 15455000.0 (Q4 2025), 8250000.0 (Q3 2025), and 13301000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | -15.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.46 Mn |
| Dec 31, 2025 | -15.46 Mn |
| Sep 30, 2025 | -8.25 Mn |
| Sep 30, 2025 | -8.25 Mn |
| Jun 30, 2025 | -13.30 Mn |
| Jun 30, 2025 | -13.30 Mn |
| Mar 31, 2025 | -21.13 Mn |
| Mar 31, 2025 | -21.13 Mn |
| Dec 31, 2024 | -37.61 Mn |
| Dec 31, 2024 | -37.61 Mn |
| Sep 30, 2024 | -41.07 Mn |
| Sep 30, 2024 | -41.07 Mn |
| Jun 30, 2024 | -41.60 Mn |
| Jun 30, 2024 | -41.60 Mn |
| Mar 31, 2024 | -50.21 Mn |
| Mar 31, 2024 | -50.21 Mn |
| Dec 31, 2023 | -59.24 Mn |
| Dec 31, 2023 | -59.24 Mn |
| Sep 30, 2023 | -35.35 Mn |
| Sep 30, 2023 | -35.35 Mn |